These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 21300830)
1. Penetration of meropenem into epithelial lining fluid of patients with ventilator-associated pneumonia. Lodise TP; Sorgel F; Melnick D; Mason B; Kinzig M; Drusano GL Antimicrob Agents Chemother; 2011 Apr; 55(4):1606-10. PubMed ID: 21300830 [TBL] [Abstract][Full Text] [Related]
2. Telavancin penetration into human epithelial lining fluid determined by population pharmacokinetic modeling and Monte Carlo simulation. Lodise TP; Gotfried M; Barriere S; Drusano GL Antimicrob Agents Chemother; 2008 Jul; 52(7):2300-4. PubMed ID: 18426898 [TBL] [Abstract][Full Text] [Related]
3. Penetration of vancomycin into epithelial lining fluid in healthy volunteers. Lodise TP; Drusano GL; Butterfield JM; Scoville J; Gotfried M; Rodvold KA Antimicrob Agents Chemother; 2011 Dec; 55(12):5507-11. PubMed ID: 21911567 [TBL] [Abstract][Full Text] [Related]
4. Meropenem penetration into epithelial lining fluid in mice and humans and delineation of exposure targets. Drusano GL; Lodise TP; Melnick D; Liu W; Oliver A; Mena A; VanScoy B; Louie A Antimicrob Agents Chemother; 2011 Jul; 55(7):3406-12. PubMed ID: 21576431 [TBL] [Abstract][Full Text] [Related]
5. Is One Sample Enough? β-Lactam Target Attainment and Penetration into Epithelial Lining Fluid Based on Multiple Bronchoalveolar Lavage Sampling Time Points in a Swine Pneumonia Model. Motos A; Kuti JL; Li Bassi G; Torres A; Nicolau DP Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30509937 [TBL] [Abstract][Full Text] [Related]
6. Impact of meropenem in combination with tobramycin in a murine model of Pseudomonas aeruginosa pneumonia. Louie A; Liu W; Fikes S; Brown D; Drusano GL Antimicrob Agents Chemother; 2013 Jun; 57(6):2788-92. PubMed ID: 23571540 [TBL] [Abstract][Full Text] [Related]
7. Determination of meropenem penetration into the lung from Sparse data. Kees MG; Lodise TP; Drusano GL Antimicrob Agents Chemother; 2011 Dec; 55(12):5959-61. PubMed ID: 22081725 [No Abstract] [Full Text] [Related]
8. Pharmacodynamics of levofloxacin in a murine pneumonia model of Pseudomonas aeruginosa infection: determination of epithelial lining fluid targets. Louie A; Fregeau C; Liu W; Kulawy R; Drusano GL Antimicrob Agents Chemother; 2009 Aug; 53(8):3325-30. PubMed ID: 19364849 [TBL] [Abstract][Full Text] [Related]
10. Modelled target attainment after meropenem infusion in patients with severe nosocomial pneumonia: the PROMESSE study. Frippiat F; Musuamba FT; Seidel L; Albert A; Denooz R; Charlier C; Van Bambeke F; Wallemacq P; Descy J; Lambermont B; Layios N; Damas P; Moutschen M J Antimicrob Chemother; 2015 Jan; 70(1):207-16. PubMed ID: 25216821 [TBL] [Abstract][Full Text] [Related]
11. Pharmacodynamics of ceftazidime and meropenem in cerebrospinal fluid: results of population pharmacokinetic modelling and Monte Carlo simulation. Lodise TP; Nau R; Kinzig M; Drusano GL; Jones RN; Sörgel F J Antimicrob Chemother; 2007 Nov; 60(5):1038-44. PubMed ID: 17785282 [TBL] [Abstract][Full Text] [Related]
12. Pharmacodynamics of meropenem in critically ill patients with ventilator-associated pneumonia. Jaruratanasirikul S; Kositpantawong N; Jullangkoon M; Aeinlang N; Wongpoowarak W J Med Assoc Thai; 2013 Oct; 96(10):1283-9. PubMed ID: 24350408 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of Epithelial Lining Fluid Concentration of Amikacin in Critically Ill Patients With Ventilator-Associated Pneumonia. Najmeddin F; Shahrami B; Azadbakht S; Dianatkhah M; Rouini MR; Najafi A; Ahmadi A; Sharifnia H; Mojtahedzadeh M J Intensive Care Med; 2020 Apr; 35(4):400-404. PubMed ID: 29471721 [TBL] [Abstract][Full Text] [Related]
14. Synergistic Meropenem-Tobramycin Combination Dosage Regimens against Clinical Hypermutable Pseudomonas aeruginosa at Simulated Epithelial Lining Fluid Concentrations in a Dynamic Biofilm Model. Bilal H; Bergen PJ; Kim TH; Chung SE; Peleg AY; Oliver A; Nation RL; Landersdorfer CB Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31427301 [TBL] [Abstract][Full Text] [Related]
15. Intrapulmonary pharmacokinetics of antibiotics used to treat nosocomial pneumonia caused by Gram-negative bacilli: A systematic review. Heffernan AJ; Sime FB; Lipman J; Dhanani J; Andrews K; Ellwood D; Grimwood K; Roberts JA Int J Antimicrob Agents; 2019 Mar; 53(3):234-245. PubMed ID: 30472292 [TBL] [Abstract][Full Text] [Related]
16. Imipenem, meropenem, or doripenem to treat patients with Pseudomonas aeruginosa ventilator-associated pneumonia. Luyt CE; Aubry A; Lu Q; Micaelo M; Bréchot N; Brossier F; Brisson H; Rouby JJ; Trouillet JL; Combes A; Jarlier V; Chastre J Antimicrob Agents Chemother; 2014; 58(3):1372-80. PubMed ID: 24342638 [TBL] [Abstract][Full Text] [Related]
17. Population Pharmacokinetics and Target Attainment of Meropenem in Plasma and Tissue of Morbidly Obese Patients after Laparoscopic Intraperitoneal Surgery. Wittau M; Scheele J; Kurlbaum M; Brockschmidt C; Wolf AM; Hemper E; Henne-Bruns D; Bulitta JB Antimicrob Agents Chemother; 2015 Oct; 59(10):6241-7. PubMed ID: 26248353 [TBL] [Abstract][Full Text] [Related]
18. Clinical pharmacokinetics of meropenem and biapenem in bile and dosing considerations for biliary tract infections based on site-specific pharmacodynamic target attainment. Ikawa K; Nakashima A; Morikawa N; Ikeda K; Murakami Y; Ohge H; Derendorf H; Sueda T Antimicrob Agents Chemother; 2011 Dec; 55(12):5609-15. PubMed ID: 21947393 [TBL] [Abstract][Full Text] [Related]
19. Intrapulmonary pharmacokinetics of high doses of tigecycline in patients with ventilator-associated pneumonia. Dimopoulos G; Almyroudi MP; Kapralos I; Apostolopoulou O; Flevari A; Nicolau DP; Dokoumetzidis A Int J Antimicrob Agents; 2022 Jan; 59(1):106487. PubMed ID: 34843925 [TBL] [Abstract][Full Text] [Related]